The market for Ozempic and similar GLP-1 receptor agonists is booming, driven by their effectiveness in promoting weight loss and addressing other health conditions.
With fears of an economic hard landing abating and rates expected to stay higher for longer, can a greater allocation to high yield boost multi-asset credit returns?
With interest rate volatility likely to continue, Muzinich & Co explains how investors can insulate their credit exposure while potentially generating compelling returns via an allocation to short-duration...
Changes to the UK's listing regime confirmed by the FCA in July are the result of several years of wrangling -what are the opportunities and risks for investors?
Sophisticated private wealth investors are increasingly exploring the benefits of combining various commercial real estate strategies in their portfolios.